+1 Recommend
0 collections
      • Record: found
      • Abstract: found
      • Article: not found

      PTSD symptom reduction with mindfulness-based stretching and deep breathing exercise: randomized controlled clinical trial of efficacy.

      The Journal of Clinical Endocrinology and Metabolism

      Academic Medical Centers, Adrenocorticotropic Hormone, blood, secretion, Aged, Breathing Exercises, Dehydroepiandrosterone Sulfate, Down-Regulation, Female, Follow-Up Studies, Humans, Hydrocortisone, Male, Middle Aged, Muscle Stretching Exercises, Neurosecretory Systems, physiopathology, New Mexico, Nurses, Psychiatric Status Rating Scales, Psychophysiology, Severity of Illness Index, Stress Disorders, Post-Traumatic, psychology, therapy

      Read this article at

          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.


          Abnormal cortisol levels are a key pathophysiological indicator of post-traumatic stress disorder (PTSD). Endogenous normalization of cortisol concentration through exercise may be associated with PTSD symptom reduction. The aim of the study was to determine whether mindfulness-based stretching and deep breathing exercise (MBX) normalizes cortisol levels and reduces PTSD symptom severity among individuals with subclinical features of PTSD. A randomized controlled trial was conducted at the University of New Mexico Health Sciences Center. Twenty-nine nurses (28 female) aged 45-66 years participated in the study. Sixty-minute MBX sessions were conducted semiweekly for 8 weeks. Serum cortisol was measured, and the PTSD Checklist-Civilian version (PCL-C) was performed at baseline and weeks 4, 8, and 16. Twenty-nine participants completed the study procedures, 22 (79%) with PTSD symptoms (MBX, n = 11; control, n = 11), and 7 (21%) without PTSD (BASE group). Eight-week outcomes for the MBX group were superior to those for the control group (mean difference for PCL-C scores, -13.6; 95% confidence interval [CI], -25.6, -1.6; P = .01; mean difference for serum cortisol, 5.8; 95% CI, 0.83, 10.8; P = .01). No significant differences were identified between groups in any other items. The changes in the MBX group were maintained at the 16-week follow-up (P = .85 for PCL-C; P = .21 for cortisol). Our data show that improved PTSD scores were associated with normalization of cortisol levels (P < .05). The results suggest that MBX appears to reduce the prevalence of PTSD-like symptoms in individuals exhibiting subclinical features of PTSD.

          Related collections

          Author and article information



          Comment on this article